NervGen Pharma Corp. (TSXV:NGEN)
Canada · Delayed Price · Currency is CAD 5.55
+0.15 (2.78%)
Feb 11, 2026, 3:59 PM EST
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of CAD 430.11 million as of February 11, 2026. Its market cap has increased by 113.54% in one year.
Market Cap
430.11M
Enterprise Value
418.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.55
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 50.07M to 430.11M, an increase of 758.99%. That is a compound annual growth rate of 36.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 430.11M | -29.64% |
| Dec 31, 2025 | 611.28M | 176.89% |
| Dec 31, 2024 | 220.77M | 37.18% |
| Dec 29, 2023 | 160.94M | 71.42% |
| Dec 30, 2022 | 93.89M | -24.19% |
| Dec 31, 2021 | 123.84M | 58.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.02B |
| Eupraxia Pharmaceuticals | 580.43M |
| Satellos Bioscience | 319.63M |
| Helix BioPharma | 139.77M |
| Medicenna Therapeutics | 68.40M |
| ME Therapeutics Holdings | 68.21M |
| Sharp Therapeutics | 66.17M |
| NurExone Biologic | 61.66M |